List of Excipients in API hydrocodone bitartrate and guaifenesin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydrocodone bitartrate and guaifenesin
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Sovereign Pharmaceuticals LLC | OBREDON | hydrocodone bitartrate and guaifenesin | 58716-433 | CITRIC ACID MONOHYDRATE | 2035-11-13 |
Sovereign Pharmaceuticals LLC | OBREDON | hydrocodone bitartrate and guaifenesin | 58716-433 | GLYCERIN | 2035-11-13 |
Sovereign Pharmaceuticals LLC | OBREDON | hydrocodone bitartrate and guaifenesin | 58716-433 | METHYLPARABEN | 2035-11-13 |
Sovereign Pharmaceuticals LLC | OBREDON | hydrocodone bitartrate and guaifenesin | 58716-433 | POTASSIUM CITRATE | 2035-11-13 |
Sovereign Pharmaceuticals LLC | OBREDON | hydrocodone bitartrate and guaifenesin | 58716-433 | POTASSIUM SORBATE | 2035-11-13 |
Sovereign Pharmaceuticals LLC | OBREDON | hydrocodone bitartrate and guaifenesin | 58716-433 | PROPYLENE GLYCOL | 2035-11-13 |
Sovereign Pharmaceuticals LLC | OBREDON | hydrocodone bitartrate and guaifenesin | 58716-433 | PROPYLPARABEN | 2035-11-13 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for hydrocodone bitartrate and guaifenesin
Excipient focus: CITRIC ACID MONOHYDRATE
hydrocodone bitartrate and guaifenesin drug variants containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
hydrocodone bitartrate and guaifenesin drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
hydrocodone bitartrate and guaifenesin drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CITRATE
hydrocodone bitartrate and guaifenesin drug variants containing POTASSIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing POTASSIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
hydrocodone bitartrate and guaifenesin drug variants containing POTASSIUM SORBATE
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing POTASSIUM SORBATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydrocodone bitartrate and guaifenesin drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
hydrocodone bitartrate and guaifenesin drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
hydrocodone bitartrate and guaifenesin drug variants containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
hydrocodone bitartrate and guaifenesin drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Sovereign Pharmaceuticals LLC | hydrocodone bitartrate and guaifenesin | 58716-433 |
>Company | >Ingredient | >NDC |
hydrocodone bitartrate and guaifenesin drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.